Navigation Links
InterMune Reports Results from Triple Combination Study of ITMN-191
Date:1/12/2009

(the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) risks related to the long, expensive and uncertain clinical development and regulatory process, including having no unexpected safety, toxicology, clinical or other issues or delays in anticipated timing of the regulatory approval process; (ii) risks related to failure to achieve the clinical trial results required to commercialize our product candidates; and (iii) risks related to timely patient enrollment and retention in clinical trials. The risks and other factors discussed above should be considered only in connection with the fully discussed risks and other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web site at www.intermune.com.

Pegasys(R) and Copegus(R) are registered trademarks of Roche.


'/>"/>
SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. InterMune to Present at Thomas Weisel Partners Healthcare Conference
2. Former InterMune CEO W. Scott Harkonen Indicted for Wire Fraud and FDA Violations
3. InterMune to Present at the 2008 Wachovia Healthcare Conference
4. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
5. LegalView Reports Traumatic Brain Injury Study Concluding Spirituality Increases Following Brain Damage
6. Allscripts Reports Fiscal 2009 Second Quarter Results
7. MDS Reports Final Fourth-Quarter 2008 Results
8. Consumer Reports: Big Promises of Some Infomercial Exercise Machines Fall Flat; Plus, Set Up a Home Gym for Under $100
9. Cardium Reports on Exchange Listing With NYSE Alternext US
10. CellCyte Genetics Corporation: Seattle Times Erroneously Reports That CellCyte Closes
11. Joint Commission Reports Positive Survey Results for CHA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 23, 2014 Florida Hospital Zephyrhills ... renovated Women’s Health Center on Wednesday, September 24. ... the specially designed center offers a new level ... County. The Women’s Health Center offers comprehensive women’s ... labor and delivery through The Baby Place®, and ...
(Date:9/23/2014)... published studies found that FDG-PET technology is less ... in regions where infections like histoplasmosis or tuberculosis ... for cancer could lead to unnecessary tests and ... mortality. , Histoplasmosis and other fungal diseases ... in bird droppings and are found in soils. ...
(Date:9/23/2014)... Sinica, the preeminent academic institution in the Republic ... agreement to develop a unique educational and scientific ... to translate innovative technologies and commercially relevant discoveries ... Sept.12 in Taipei by Harris Lewin, vice chancellor ... Wong of Academia Sinica. The program will be ...
(Date:9/23/2014)... From first-hand experience, Matthew O'Farrell knows all about ... can be treated. , A medically retired Army veteran, ... platoon sustained multiple attacks resulting in five casualties. After ... PTSD and honorably discharged from the Army. , “I ... myself from my friends and family,” recalled O’Farrell, who ...
(Date:9/23/2014)... As a consumer in today’s world, ... It’s difficult to trust testimonials that are supplied by ... manipulate their customers into saying anything. , Consumer advocacy ... to lack in depth coverage on a particular market ... to fix this issue and focus on exposing the ...
Breaking Medicine News(10 mins):Health News:Florida Hospital Zephyrhills Celebrates Grand Opening of Women’s Health Center 2Health News:Florida Hospital Zephyrhills Celebrates Grand Opening of Women’s Health Center 3Health News:Study questions accuracy of lung cancer screens in some geographic regions 2Health News:Academia Sinica, UC Davis sign agreement on exchanges and tech transfer 2Health News:Virtual Reality software to help treat PTSD 2Health News:Virtual Reality software to help treat PTSD 3Health News:Consumer Health Reports Debuts Revolutionary Review Website 2
... in those who also have heart disease , TUESDAY, Aug. ... prostate cancer and who also have underlying heart disease may ... In fact, such hormone therapy may actually increase their odds ... attack or heart failure, use of hormone therapy for prostate ...
... ... Health System to stable, citing the health system,s "improving financial metrics" and "better-than-expected ... ... its outlook for Wellmont Health System to stable, citing the health system,s ...
... , SAN DIEGO, Aug. 25 CareFusion ... 500 index following the company,s planned spinoff from Cardinal Health on Aug. ... 1, coinciding with its first day of regular-way trading on the New ... "Our inclusion in the S&P 500 is a testament to our ...
... , , , ... the ideal time to honor the life of a beloved pet--yours or someone ... lost pet and also offer animal lovers an opportunity to improve the future ... are customized with the names of the pet owner and the pet ...
... the anti-cancer drug, experts say , TUESDAY, Aug. 25 (HealthDay ... lower the chances of developing the most common type of ... raises the risk of getting a more aggressive cancer in ... the finding is no reason to ditch the anti-cancer drug, ...
... , IRVINE, Calif., Aug. 25 Masimo ... and Measure-Through Motion and Low-Perfusion pulse oximetry, announced today that ... Report as one of ,America,s Best Children,s Hospitals, has completed ... , , Masimo SET has been clinically ...
Cached Medicine News:Health News:Hormone Therapy for Early Prostate Cancer Not Always Best 2Health News:Hormone Therapy for Early Prostate Cancer Not Always Best 3Health News:Standard & Poor's Upgrades Wellmont Outlook 2Health News:Standard & Poor's Upgrades Wellmont Outlook 3Health News:CareFusion Corp to be Included in S&P 500 Index 2Health News:Honor Spirit and Memory of a Special Pet During National Pet Memorial Month 2Health News:Tamoxifen May Up Risk of Second, More Aggressive Breast Cancer 2Health News:Childrens Hospital Los Angeles Completes Conversion to Masimo SET(R) Pulse Oximetry Technology 2Health News:Childrens Hospital Los Angeles Completes Conversion to Masimo SET(R) Pulse Oximetry Technology 3Health News:Childrens Hospital Los Angeles Completes Conversion to Masimo SET(R) Pulse Oximetry Technology 4Health News:Childrens Hospital Los Angeles Completes Conversion to Masimo SET(R) Pulse Oximetry Technology 5
(Date:9/23/2014)... Sept. 23, 2014 The Pennsylvania State Police will ... 27, as part of National Prescription Drug Take-Back Day. ... Take-Back Day is a national initiative, conducted ... aimed at encouraging the public to dispose of expired, ... abuse and theft. From 10 a.m. to ...
(Date:9/23/2014)... Canada , September 23, 2014 ... and lifestyle related disorders and increasing number of foreign ... demand for probiotic in India ... as one of the most high growth potential markets ... concerns among consumers especially among the youth, changing food ...
(Date:9/23/2014)... 23, 2014  KemPharm, Inc., a clinical-stage specialty ... of proprietary new molecular entity (NME) prodrugs, announced ... (NOL) from Health Canada to begin clinical trials ... lead product candidate KP201 (benzhydrocodone hydrochloride and acetaminophen).  ... acute moderate to moderately severe pain. The Health ...
Breaking Medicine Technology:India Probiotic Market Pegged to Grow at Around 20% by 2019, Says TechSci Research 2India Probiotic Market Pegged to Grow at Around 20% by 2019, Says TechSci Research 3KemPharm Receives Health Canada Approval to Begin KP201 Clinical Trials in Canada 2KemPharm Receives Health Canada Approval to Begin KP201 Clinical Trials in Canada 3
... , MOUNTAIN VIEW, Calif. , Feb. 16 ... it will host an investor/analyst meeting on Thursday, February 18, 2010 ... New York City . , The meeting will include presentations from: , ... James Cassella , PhD - SVP, Research and Development, ...
... , LAWRENCEVILLE, N.J. , Feb. 16 ... announced today that Wayne S. Mulcahy , Ph.D., ... A wholly owned subsidiary of Princeton Pharma Holdings LLC, ... unique products in ophthalmology and orphan diseases. , ...
Cached Medicine Technology:Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010 2Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010 3Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010 4Aton Pharma Appoints Dr. Wayne Mulcahy to Vice President, Clinical Operations 2
The Tano Asymmetrical Microforceps features an offset tip which allows optimal visualization along the entire tip length. Versatile tip design targets ILM, fine epiretinal membranes and diabetic or P...
Microforceps : Asymmetrical Endgripping Forceps...
Pic forceps design that is slightly curved; tips have special "surface treatment" for enhanced manipulation of the retina....
Microforceps : Eckardt Endgripping Forceps...
Medicine Products: